Frontlight ResearchEarly access
Active, not recruitingNo phase
Aberrant Synaptic Plasticity in Cocaine Use Disorder: A 11C-UCB-J PET Study
Key facts
- Who runs it
- Yale University
- Where
- New Haven, United StatesSee the site
- Trial code
- Status
- Active, not recruiting
- People taking part
- 80 people, planned
- Started
- 20 Jul 2021
- Expected to end
- Apr 2027
- Type of study
- Observational, 2 groups
- Treatments tested
- 11C-UCB-J
- Record updated
- 25 August 2026
Who can take part
- Age
- 21 years to 60 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (10)Hide the full registry criteria
Who can take part
- Age 21-60 years
- Physically healthy by medical history, physical, neurological, ECG and laboratory examinations
- For females, a negative serum pregnancy test
- For CUD: DSM-5 criteria for Cocaine Use Disorder and positive urine toxicology showing recent use
- For HC: Negative urine toxicology
Who cannot take part
- Current use of psychotropic and/or potentially psychoactive prescription medications
- DSM-5 criteria for other substance use disorders (e.g., alcohol, opiates, sedative hypnotics), except for nicotine
- A primary DSM-5 Axis I major psychiatric disorder (e.g., schizophrenia, bipolar disorder, major depression, etc.) as determined by the Structured Clinical Interview for DSM-5 (SCID-5)
- A history of significant and/or uncontrolled medical or neurological illness
- Medical contraindications to MRI procedure
Where in United States
- Connecticut Mental Health CenterNew Haven, United States
About the trial
What the trial wants to find out
The purpose of this research study is to measure synaptic density in the brain comparing individuals with cocaine use disorder to healthy controls.
The 2 groups in the trial
- Cocaine Use Disorder
Treatment: 11C-UCB-J
- Healthy Control
Treatment: 11C-UCB-J
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 25 August 2026